Independent Advisor Alliance Dexcom Inc Transaction History

Independent Advisor Alliance

$2.71 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$110.31 - $140.45 $1,764 - $2,247	16 Added 0.43%	3,726 $422,000
Q1 2024 May 08, 2024	SELL	$114.22 - $140.1 $1,256 - $1,541	-11 Reduced 0.3%	3,710 $514,000
Q4 2023 Feb 08, 2024	SELL	$75.49 - $124.16 $981 - $1,614	-13 Reduced 0.35%	3,721 $461,000
Q3 2023 Oct 24, 2023	SELL	$86.06 - $137.93 $6,110 - $9,793	-71 Reduced 1.87%	3,734 $348,000
Q2 2023 Jul 28, 2023	BUY	$112.47 - $130.98 $7,198 - $8,382	64 Added 1.71%	3,805 $488,000
Q1 2023 May 12, 2023	BUY	$104.0 - $122.92 $389,064 - $459,843	3,741 New	3,741 $434,000
Q3 2022 Nov 04, 2022	SELL	$76.35 - $94.18 $79,938 - $98,606	-1,047 Reduced 17.59%	4,905 $395,000
Q2 2022 Aug 04, 2022	BUY	$67.99 - $132.89 $296,980 - $580,463	4,368 Added 275.76%	5,952 $444,000
Q1 2022 May 06, 2022	SELL	$94.08 - $130.2 $3,575 - $4,947	-38 Reduced 2.34%	1,584 $810,000
Q4 2021 Feb 11, 2022	BUY	$129.87 - $162.82 $23,506 - $29,470	181 Added 12.56%	1,622 $871,000
Q3 2021 Nov 01, 2021	SELL	$106.71 - $143.18 $11,204 - $15,033	-105 Reduced 6.79%	1,441 $788,000
Q2 2021 Aug 12, 2021	SELL	$80.99 - $107.93 $971 - $1,295	-12 Reduced 0.77%	1,546 $660,000
Q1 2021 May 14, 2021	BUY	$84.79 - $104.74 $1,356 - $1,675	16 Added 1.04%	1,558 $560,000
Q4 2020 Feb 11, 2021	BUY	$78.0 - $104.5 $15,834 - $21,213	203 Added 15.16%	1,542 $570,000
Q3 2020 Nov 04, 2020	BUY	$95.51 - $112.95 $127,887 - $151,240	1,339 New	1,339 $552,000
Q1 2019 May 07, 2019	SELL	$28.07 - $38.18 $102,174 - $138,975	-3,640 Closed	0 $0
Q4 2018 Feb 12, 2019	BUY	$26.99 - $37.37 $98,243 - $136,026	3,640 New	3,640 $436,000

Others Institutions Holding DXCM

# of Institutions

1,014

Shares Held

351M

Call Options Held

5.51M

Put Options Held

5.6M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $30.9B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Independent Advisor Alliance, based on Form 13F filings with the SEC.

News

Stay updated on Independent Advisor Alliance with notifications on news.

Account